2016 Guidelines For Newborn Blood Spot. NHS
2016 Guidelines For Newborn Blood Spot. NHS
Sampling
Public Health England leads the NHS Screening Programmes
Contents
About Public Health England
Contents
Executive summary
Introduction
12
14
21
5. Special circumstances: babies born preterm or cared for in hospital specialist units
23
27
32
8. Additional resources
32
References
33
Appendices
38
Glossary
42
Abbreviations
49
Acknowledgments
50
Executive summary
These guidelines are intended to provide a consistent and clear approach to newborn blood
spot sampling. They aim to support promotion of newborn blood spot screening, informed
choice and collection of good quality blood spot samples. They are written for the screening
programme in England.
The guidelines explain why blood spot quality is important, the equipment needed, how to take
and record consent, how to complete the blood spot card and how to take good quality blood
spot samples. The guidelines also describe what to do in special circumstances, for example if
the baby is born preterm, and how to ensure that all eligible babies are offered screening.
Introduction
Newborn blood spot (NBS) screening identifies babies who may have rare but serious
conditions. The UK National Screening Committee (UK NSC) recommends that all
babies are offered screening for sickle cell disease (SCD), cystic fibrosis (CF),
congenital hypothyroidism (CHT) and six inherited metabolic diseases (IMDs):
phenylketonuria (PKU), medium-chain acyl-CoA dehydrogenase deficiency (MCADD),
maple syrup urine disease (MSUD), isovaleric acidaemia (IVA), glutaric aciduria type 1
(GA1) and homocystinuria (pyridoxine unresponsive) (HCU). Screening for MSUD, IVA,
GA1 and HCU was introduced in England and Wales in January 2015.
For the small number of babies affected, early detection, referral and treatment can help
to improve their health and prevent severe disability or even death. Without early
treatment, the conditions screened for can result in:
SCD
CF
CHT
PKU
MCADD
MSUD
IVA
GA1
HCU
These guidelines
These guidelines are written for the screening programme in England. Healthcare workers in
Northern Ireland, Scotland and Wales must be aware of variation in practice and conditions
screened for when referring to these guidelines.
Units are encouraged to develop local processes in line with these guidelines that
demonstrate lines of responsibility.
5
2. falsely high analyte concentrations (false-positive results), which can be caused by:
Poor quality blood spots could therefore lead to false-negative or false-positive screening
results this means that babies with a condition might be missed or babies without a
condition might be referred for further tests unnecessarily.
Avoidable repeats
If poor quality blood spots are received, or the fields on the blood spot card are not completed
fully and accurately, the screening laboratory will request an avoidable repeat sample.
Avoidable repeat samples can cause anxiety for parents, distress to babies and delays in the
screening process. This could lead to a baby missing CF screening because it can only be
screened up to eight weeks or to delayed identification and treatment of an affected baby.
Avoidable repeats are also a waste of healthcare resources (each repeat costs the NHS around
100). In some cases, parents may refuse to consent to a repeat this means that the baby
will have incomplete screening.
Newborn screening laboratories in England are following a national, evidence-based
consensus on blood spot quality, with standardised acceptance and rejection criteria. To
ensure that an avoidable repeat sample is not requested, sample takers are advised to obtain
four good quality blood spots and complete all fields on the blood spot card accurately.
NHS Screening Programmes booklet Screening tests for you and your baby
babys NHS number (use of a bar-coded label is recommended)
blood spot card and glassine envelope
personal child health record (PCHR) and maternity/professional record
water for cleansing
non-sterile protective gloves
age-appropriate, automated incision device* (manual lancets must not be used)
sharps box
cotton wool/gauze
hypoallergenic spot plaster (if required)
prepaid/stamped addressed envelope (first class) (if not using a courier)
*there is some evidence that an arch-shaped incision device is more effective in providing a
good quality sample see section 3.5.
1.1
1.2
1.3
Ensure parents still have access to the prescreening booklet at least 24 hours before
taking the sample. If not, ensure a copy of the
booklet is available to parents.
8
1.4
1.5
1.6
1.7
1.8
1.9
visitor (see
www.gov.uk/government/publication
s/declined-newborn-blood-spotscreening-template-letters for a
template to adapt for local use)
inform the NBS lead
midwife/manager
1.10
11
Reasoning
2.1
2.2
2.3
available (below)
apply one label to each sheet of the
blood spot card at the time of
sampling (do not apply in advance
of the test)
Use block capital letters to complete all
fields on the blood spot card that are not
included on the bar-coded label.
2.4
2.5
13
Reasoning
3.1
3.2
3.3
14
3.4
3.5
15
recommended. [38]
Avoid posterior curvature of the heel.
3.6
Figure 2
For infants who have had repeated
heel punctures
3.7
17
3.8 Figure 3
Correct
Reasoning
Incorrect
Reasoning
Inappropriate application of
blood: multispotted (that is,
several small spots of blood)
Compressed sample
front of card
back of card
18
Inappropriate application of
blood: layered sample (for
example one spot of blood is
layered directly on top of
another) or blood applied to the
front and the back of the blood
spot card
Contaminated sample
(images of real samples courtesy of Wyn Griffiths, South East Thames Screening Laboratory
and Roanna George, Wales Newborn Screening Laboratory)
19
3.9
3.10
3.11
3.12
20
Reasoning
4.1
21
4.2
4.3
22
Reasoning
5.2
23
5.3
5.4
5.5
To permit appropriate
interpretation of results.
5.6
5.7
5.8
5.9
26
Reasoning
6.1
27
6.2
28
insufficient sample
inappropriate application of
blood
compressed, damaged or
contaminated sample
29
damaged in transit
6.3
31
acceptable level: the avoidable blood spot repeat rate is less than or equal to 2%
achievable level: the avoidable blood spot repeat rate is less than or equal to 0.5%
Data is collated and published by the NHS Screening Programmes KPI team and the
NBS programme. The Screening Quality Assurance Service monitors the data to check that the
standard is being met and encourages continuous improvement.
8. Additional resources
online learning modules on improving blood spot quality and expanded newborn
screening: cpd.screening.nhs.uk/bloodspot-elearning
short films, including a video of a community midwife discussing how she improved
her avoidable repeat rate: cpd.screening.nhs.uk/newbornbloodspot
interactive blood spot card: cpd.screening.nhs.uk/interactivecard.php
standards for newborn blood spot screening [44]
There may also be local initiatives to support you in taking good quality blood spot samples
speak to your local screening coordinator or regional screening quality assurance service.
32
References
1. National Institute for Clinical Excellence (2008) Antenatal Care: NICE guidelines [CG62]
[Online] Available at: www.nice.org.uk/guidance/cg62 (accessed 08 July 2015).
2. Department of Health (2009) Reference Guide to Consent for Examination or Treatment, 2 nd
edition [Online] Available at:
www.gov.uk/government/uploads/system/uploads/attachment_data/file/138296/dh_103653_
_1_.pdf (accessed 08 July 2015).
3. Department of Health/Partnerships for Children, Families and Maternity (2007) Maternity
matters: choice, access and continuity of care in a safe service [Online] Available at:
webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_d
h/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_074199.pdf (accessed 08
July 2015).
4. Detmar, S., et al. (2007) Information and informed consent for neonatal screening: opinions
and preferences of parents. Birth, 34(3): p. 238-44.
5. Parsons, E.P., et al. (2007) Mothers accounts of screening newborn babies in Wales (UK).
Midwifery, 23(1): p. 59-65.
6. Davis, T.C., et al. (2006) Recommendations for effective newborn screening
communication: results of focus groups with parents, providers, and experts. Pediatrics,
117(5 Pt 2): p. S326-40.
7. Pittam, G. and Allaby, M. (2012) A report for the UK National Screening Committee
Informed Consent in Antenatal and Newborn Screening. Solutions for Public Health: Oxford.
8. NHS England (2014) NHS public health Functions agreement 2015-16 Service specification
no.19, NHS Newborn Blood Spot Screening Programme [Online] Available at:
www.gov.uk/government/publications/public-health-commissioning-in-the-nhs-2015-to-2016
(accessed: 08 July 2015).
9. NHS Newborn Blood Spot Screening Programme (2015) A laboratory guide to newborn
blood spot screening for inherited metabolic diseases [Online] Available at:
www.gov.uk/government/publications/newborn-blood-spot-screening-laboratory-guide-forimds (accessed 06 August 2015).
10. The Royal College of Midwives (2015) The Role and Responsibilities of Maternity Support
Workers [Online] Available at:
33
www.rcm.org.uk/sites/default/files/MSW%20Guide%20January%202015.pdf (accessed 28
January 2016).
11. Nursing and Midwifery Council (2012) Midwives Rules and Standards [Online] Available at:
www.nmc.org.uk/standards/additional-standards/midwives-rules-and-standards/ (accessed
08 July 2015).
12. Nursing and Midwifery Council (2009) Record Keeping: Guidance for Nurses and Midwives,
[Online] Available at:
www.nipec.hscni.net/Image/SitePDFS/nmcGuidanceRecordKeepingGuidanceforNursesand
Midwives.pdf (accessed 08 July 2015).
13. Nursing and Midwifery Council (2015) The Code: Professional standards of practice and
behaviour for nurses and midwives [Online] Available at:
www.nmc.org.uk/globalassets/sitedocuments/nmc-publications/revised-new-nmc-code.pdf
(accessed 06 August 2015).
14. UK Newborn Screening Programme Centre (2005) Code of Practice for the Retention and
Storage of Residual Spots [Online] Available at:
www.gov.uk/government/publications/newborn-blood-spot-screening-code-of-practice-forthe-retention-and-storage-of-residual-spots (accessed 08 July 2015).
15. Department of Health (2006) The National Health Service Act 2006, The National Health
Service (Wales) Act 2006 and The National Health Service (Consequential Provisions) Act
2006: London.
16. NHS Newborn Blood Spot Screening Programme / NHS Connecting for Health (2014) NHS
Numbers for Newborn Screening: Output Based Specification for the Blood Spot Card Label
v3.4 [Online] Available at: www.gov.uk/government/publications/nhs-numbers-for-newbornscreening-specification-for-the-blood-spot-card-label (accessed 06 August 2015).
17. Morrow, C., Hidinger, A. and Wilkinson-Faulk, D. (2010) Reducing neonatal pain during
routine heel lance procedures. MCN Am J Matern Child Nurs, 35(6): p. 346-54; quiz 354-6.
18. Shepherd, A., Glenesk, A. and Niven, C. (2006) What influence does experience play in
heel prick blood sampling? J Neonatal Nursing, 12(3).
19. Shah, P.S., Aliwalas, L.I. and Shah, V. (2006) Breastfeeding or breast milk for procedural
pain in neonates. Cochrane Database Syst Rev, 3: p. CD004950.
20. Yilmaz, F. and Arikan, D. (2011) The effects of various interventions to newborns on pain
and duration of crying. J Clin Nurs, 20(7-8): p. 1008-17.
34
21. Codipietro, L., Ceccarelli, M. and Ponzone, A. (2008) Breastfeeding or oral sucrose solution
in term neonates receiving heel lance: a randomized, controlled trial. Pediatrics, 122(3):p.
e716-21.
22. Uga, E., et al. (2008) Heel lance in newborn during breastfeeding: an evaluation of
analgesic effect of this procedure. Ital J Pediatr, 34(1): p. 3.
23. Taddio, A., Shah, V. and Katz, J. (2009) Reduced infant response to a routine care
procedure after sucrose analgesia. Pediatrics, 123(3): p. e425-9.
24. Stevens, B., Yamada, J. and Ohlsson, A. (2010) Sucrose for analgesia in newborn infants
undergoing painful procedures. Cochrane Database Syst Rev, p. CD001069.
25. Unicef UK (2012) Baby Friendly Initiative standards [Online] Available at:
www.unicef.org.uk/Documents/Baby_Friendly/Guidance/Baby_Friendly_guidance_2012.pdf
(accessed 09 July 2015).
26. Ray, R., Godwin, Y. and Shepherd, A. (2011) Convective burn from use of hairdryer for heel
warming prior to the heel prick test - a case report. BMC Pediatr, 11: p. 30.
27. Hassan, Z. and Shah, M. (2005) Scald injury from the Guthrie test: should the heel be
warmed? Arch Dis Child Fetal Neonatal Ed, 90(6): p. F533-4.
28. Paediatric Formulary Committee (2015) BNF for Children [Online] London: BMJ Group,
Pharmaceutical Press, and RCPCH Publications Available at:
www.evidence.nhs.uk/formulary/bnfc/current/ (accessed 24 August 2015).
29. OGrady, N.P., et al. (2011) Summary of recommendations: Guidelines for the Prevention of
Intravascular Catheter-related Infections. Clin Infect Dis, 52(9): p. 1087-99.
30. Scales, K. (2009) Correct use of chlorhexidine in intravenous practice. Nursing Standard,
24(8): p. 41-47.
31. Committee on Infectious Diseases (2007) Infection prevention and control in pediatric
ambulatory settings. Pediatrics, 120(3): p. 650-65.
32. Reynolds, P.R., Banerjee, S. and Meek, J.H. (2005) Alcohol burns in extremely low
birthweight infants: still occurring. Arch Dis Child Fetal Neonatal Ed, 90(1): p. F10.
33. Pratt, R.J., et al. (2007) epic2: National evidence-based guidelines for preventing healthcare
associated infections in NHS hospitals in England. J Hosp Infect, 65 Suppl 1: p. S1-64.
34. National Institute for Health and Care Excellence (2012), Infection: Prevention and control of
healthcare-associated infections in primary and community care NICE clinical guideline 139
35
37
Appendices
Appendix A: Blood transfusions flowchart and scenarios
5.1
Admission
Days 0-4
(day of birth = day 0)
5.2 /
5.3
5.4
Days 5-8 *
Day 5
NO
YES
Take routine
sample
(four spots)
Blood transfusion?
Take routine
sample
(four spots)
5.5
5.5
* An interval of at least
three clear days is
required between a blood
transfusion and the
routine sample for CF,
CHT and the IMDs
In the event of multiple
blood transfusions, even
if it has not been three
clear days since the last
transfusion, a routine
sample should be sent by
day 8 at the latest
= section of
guidelines
SCD
pre-transfusion
sample?
NO
YES
5.6
5.6
SCD
Send routine
sample and pretransfusion
sample to the
laboratory
SCD
Laboratory
sends routine
sample for DNA
testing
38
Scenario 1
A baby has a blood transfusion on day 4 and no further transfusions. When should the routine
sample be taken?
Solution
The routine sample should be taken on day 8. In this scenario there is no need for a repeat as
there are at least three clear days between the transfusion and the routine sample.
Scenario 2
A baby has a blood transfusion on day 5, 6 or 7. When should the routine sample be taken?
Solution
The routine sample should ideally be taken on day 5 before the transfusion.
Scenario 3
A baby is given red blood cells on day 4 and platelets on day 6. When should the routine
sample be taken and is a repeat needed?
Solution
In the event of multiple blood transfusions, even if it has not been at least three clear days
since the last transfusion, a routine blood spot sample should be sent by day 8 at the latest. In
this scenario, the routine sample should be taken on day 8 and a repeat sample taken at least
three clear days after the baby is given the last transfusion (on day 10, with days 7, 8 and 9
being the three clear days). See the calendar below for illustration.
Sunday
Monday
Tuesday
Wednesday
Day 0:
Day of birth
Thursday
Friday
Saturday
Day 1
Day 2
Day 3
Day 7
Day 8
Day 8
Day 10
Take a repeat
4 spot sample
as baby is now
3 clear days
post
transfusion
Day 14
Day 15
Day 16
Day 17
Take pretransfusion
blood spot
Day 4
Day 5
Day 11
Day 6
Baby given
platelets
Day 12
Day 13
39
Take 4 spot
sample as ALL
babies must
have a sample
sent by day 8
40
Scenario 5
A baby is born very prematurely. Should they have a CHT preterm repeat at day 28/discharge
home AND when they reach 32 weeks gestation?
Solution
No only one CHT preterm repeat is needed (at day 28 or day of discharge home, whichever
is sooner).
Scenario 6
A baby is having multiple blood transfusions around day 28. Should a repeat be taken at least
three clear days after each transfusion?
Solution
No only one repeat is needed, as soon as there is a window of at least three clear days.
Ideally this should be as close to day 28 as possible.
41
Glossary
affected
amino acid
Our bodies break down protein foods like meat and fish into amino
acids (the building blocks of protein). Any amino acids that aren't
needed are usually broken down and removed from the body.
Babies with some of the inherited metabolic diseases that are screened
for are unable to break down one or more amino acids. When levels of
these amino acids get very high, they are harmful.
antenatal
screening
audit
blood sampling
blood spot
A sample of blood that is taken from a babys heel and spotted onto a
special type of filter paper. A number of tests are then carried out on
this blood spot. These tests are often called newborn blood spot
screening.
blood
transfusion
child health
records
department (in
the past, often
referred to as
child health)
The child health records department has records of all children in the
area. When a mother gives birth the child health records department is
notified of the birth. The results of newborn and other screening tests
are also reported to child health records departments.
condition
There are lots of different words used to describe illnesses. They are
sometimes called diseases, or disorders, or conditions.
congenital
hypothyroidism
(CHT)
consent
coverage
This inherited condition affects the digestion and lungs. Babies with CF
may not gain weight well, have frequent chest infections and a limited
life span.
If babies with CF are treated early with a high-energy diet, medicines
and physiotherapy, they may live longer, healthier lives.
CF has been screened for throughout England since 2007.
diagnosis /
diagnostic test
disease
There are lots of different words used to describe illnesses. They are
sometimes called diseases, or disorders, or conditions.
disorder
There are lots of different words used to describe illnesses. They are
sometimes called diseases, or disorders, or conditions.
false-negative
result
false-positive
result
glassine
envelope
glutaric aciduria
type 1 (GA1)
homocystinuria
(HCU)
inherited
metabolic
disease
isovaleric
acidaemia (IVA)
A lancet that is pushed into the tissues by hand. It does not allow for
accurate control of the depth of the puncture.
maple syrup
urine disease
(MSUD)
medium-chain
acyl-CoA
dehydrogenase
deciency
(MCADD)
newborn
screening
normal (result)
Sometimes when the result of the test shows that the child is unlikely to
have the condition tested for, people say the result is normal.
personal child
health record
This is the child health record which is held by the parent, also called
the red book. It is normally issued by the midwife or health visitor.
phenylketonuria
(PKU)
screen-negative
result
screen-positive
result
screening
Screening is when healthy children and adults are tested to see if they
are likely to develop a condition. Screening tests dont generally
confirm that a person has a disease. Usually they will not feel ill from
these conditions in any way at the time when theyre screened.
Screening allows diseases to be identified early, before any signs of
illness. This means people can be treated quickly and hopefully avoid
getting seriously ill. Screening happens at different ages, and for
47
different conditions.
Newborn blood spot screening in England includes tests for sickle cell
disease (SCD), cystic fibrosis (CF), congenital hypothyroidism (CHT)
and six inherited metabolic diseases (IMDs): phenylketonuria (PKU),
medium-chain acyl-CoA dehydrogenase deficiency (MCADD), maple
syrup urine disease (MSUD), isovaleric acidaemia (IVA), glutaric
aciduria type 1 (GA1) and homocystinuria (pyridoxine unresponsive)
(HCU).
sickle cell
disease (SCD)
Sickle cell disease affects haemoglobin, a part of the blood that carries
oxygen around the body. Babies who have these conditions will need
specialist care throughout their lives.
People with SCD can have attacks of severe pain, get serious, lifethreatening infections and are usually anaemic (their bodies have
difficulty carrying oxygen). Babies with SCD can receive early
treatment, including immunisations and antibiotics, which, along with
support from their parents, will help reduce the chance of serious
illness and allow the child to live a healthier life.
SCD has been screened for in newborns throughout England since
2006.
UK National
Screening
Committee
NHS Newborn
Blood Spot
Screening
Programme
48
Abbreviations
CF
cystic fibrosis
CHRD
CHT
congenital hypothyroidism
EDTA
ethylenediaminetetraacetic acid
GA1
HCU
homocystinuria
IMD
IRT
immunoreactive trypsinogen
IVA
isovaleric acidaemia
KPI
MCADD
MSUD
NBS
NBSFS
PCHR
PCT
PHE
PKU
phenylketonuria
SCD
TSH
UK NSC
49
Acknowledgements
The NHS Newborn Blood Spot Screening Programme would like to thank members of the
project group (listed below) and everyone that responded to the consultation or provided
additional comments and guidance.
Amanda Ashcroft
Jim Bonham
Caroline Bridges
Parent representative
Yvonne Daniel
Maggie Denholm
Angela Dietrich
David Elliman
Roanna George
Bridget Halnan
Greta Hayward
Katie Maltby
Julie Poultney
Jane Scattergood
50